Research ArticleArticle
Obesity Is Common in Axial Spondyloarthritis and Is Associated with Poor Clinical Outcome
Fiona Maas, Suzanne Arends, Eveline van der Veer, Freke Wink, Monique Efde, Hendrika Bootsma, Elisabeth Brouwer and Anneke Spoorenberg
The Journal of Rheumatology December 2015, jrheum.150648; DOI: https://doi.org/10.3899/jrheum.150648
Fiona Maas
From the Department of Rheumatology and Clinical Immunology, Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen; Department of Rheumatology, Medical Center Leeuwarden, Leeuwarden, the Netherlands. The GLAS cohort was supported by an unrestricted grant from Pfizer. F. Maas, MSc, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; S. Arends, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, and Department of Rheumatology, Medical Center Leeuwarden; E. van der Veer, PhD, Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen; F. Wink, MD, Department of Rheumatology, Medical Center Leeuwarden; M. Efde, MD, Department of Rheumatology, Medical Center Leeuwarden; H. Bootsma, MD, PhD, Professor, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; E. Brouwer, MD, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; A. Spoorenberg, MD, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Department of Rheumatology, Medical Center Leeuwarden. Address correspondence to F. Maas, Rheumatology and Clinical Immunology, University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, the Netherlands. E-mail: f.maas@umcg.nl. Accepted for publication October 5, 2015.
Suzanne Arends
From the Department of Rheumatology and Clinical Immunology, Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen; Department of Rheumatology, Medical Center Leeuwarden, Leeuwarden, the Netherlands. The GLAS cohort was supported by an unrestricted grant from Pfizer. F. Maas, MSc, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; S. Arends, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, and Department of Rheumatology, Medical Center Leeuwarden; E. van der Veer, PhD, Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen; F. Wink, MD, Department of Rheumatology, Medical Center Leeuwarden; M. Efde, MD, Department of Rheumatology, Medical Center Leeuwarden; H. Bootsma, MD, PhD, Professor, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; E. Brouwer, MD, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; A. Spoorenberg, MD, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Department of Rheumatology, Medical Center Leeuwarden. Address correspondence to F. Maas, Rheumatology and Clinical Immunology, University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, the Netherlands. E-mail: f.maas@umcg.nl. Accepted for publication October 5, 2015.
Eveline van der Veer
From the Department of Rheumatology and Clinical Immunology, Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen; Department of Rheumatology, Medical Center Leeuwarden, Leeuwarden, the Netherlands. The GLAS cohort was supported by an unrestricted grant from Pfizer. F. Maas, MSc, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; S. Arends, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, and Department of Rheumatology, Medical Center Leeuwarden; E. van der Veer, PhD, Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen; F. Wink, MD, Department of Rheumatology, Medical Center Leeuwarden; M. Efde, MD, Department of Rheumatology, Medical Center Leeuwarden; H. Bootsma, MD, PhD, Professor, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; E. Brouwer, MD, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; A. Spoorenberg, MD, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Department of Rheumatology, Medical Center Leeuwarden. Address correspondence to F. Maas, Rheumatology and Clinical Immunology, University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, the Netherlands. E-mail: f.maas@umcg.nl. Accepted for publication October 5, 2015.
Freke Wink
From the Department of Rheumatology and Clinical Immunology, Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen; Department of Rheumatology, Medical Center Leeuwarden, Leeuwarden, the Netherlands. The GLAS cohort was supported by an unrestricted grant from Pfizer. F. Maas, MSc, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; S. Arends, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, and Department of Rheumatology, Medical Center Leeuwarden; E. van der Veer, PhD, Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen; F. Wink, MD, Department of Rheumatology, Medical Center Leeuwarden; M. Efde, MD, Department of Rheumatology, Medical Center Leeuwarden; H. Bootsma, MD, PhD, Professor, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; E. Brouwer, MD, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; A. Spoorenberg, MD, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Department of Rheumatology, Medical Center Leeuwarden. Address correspondence to F. Maas, Rheumatology and Clinical Immunology, University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, the Netherlands. E-mail: f.maas@umcg.nl. Accepted for publication October 5, 2015.
Monique Efde
From the Department of Rheumatology and Clinical Immunology, Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen; Department of Rheumatology, Medical Center Leeuwarden, Leeuwarden, the Netherlands. The GLAS cohort was supported by an unrestricted grant from Pfizer. F. Maas, MSc, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; S. Arends, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, and Department of Rheumatology, Medical Center Leeuwarden; E. van der Veer, PhD, Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen; F. Wink, MD, Department of Rheumatology, Medical Center Leeuwarden; M. Efde, MD, Department of Rheumatology, Medical Center Leeuwarden; H. Bootsma, MD, PhD, Professor, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; E. Brouwer, MD, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; A. Spoorenberg, MD, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Department of Rheumatology, Medical Center Leeuwarden. Address correspondence to F. Maas, Rheumatology and Clinical Immunology, University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, the Netherlands. E-mail: f.maas@umcg.nl. Accepted for publication October 5, 2015.
Hendrika Bootsma
From the Department of Rheumatology and Clinical Immunology, Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen; Department of Rheumatology, Medical Center Leeuwarden, Leeuwarden, the Netherlands. The GLAS cohort was supported by an unrestricted grant from Pfizer. F. Maas, MSc, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; S. Arends, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, and Department of Rheumatology, Medical Center Leeuwarden; E. van der Veer, PhD, Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen; F. Wink, MD, Department of Rheumatology, Medical Center Leeuwarden; M. Efde, MD, Department of Rheumatology, Medical Center Leeuwarden; H. Bootsma, MD, PhD, Professor, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; E. Brouwer, MD, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; A. Spoorenberg, MD, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Department of Rheumatology, Medical Center Leeuwarden. Address correspondence to F. Maas, Rheumatology and Clinical Immunology, University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, the Netherlands. E-mail: f.maas@umcg.nl. Accepted for publication October 5, 2015.
Elisabeth Brouwer
From the Department of Rheumatology and Clinical Immunology, Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen; Department of Rheumatology, Medical Center Leeuwarden, Leeuwarden, the Netherlands. The GLAS cohort was supported by an unrestricted grant from Pfizer. F. Maas, MSc, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; S. Arends, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, and Department of Rheumatology, Medical Center Leeuwarden; E. van der Veer, PhD, Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen; F. Wink, MD, Department of Rheumatology, Medical Center Leeuwarden; M. Efde, MD, Department of Rheumatology, Medical Center Leeuwarden; H. Bootsma, MD, PhD, Professor, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; E. Brouwer, MD, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; A. Spoorenberg, MD, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Department of Rheumatology, Medical Center Leeuwarden. Address correspondence to F. Maas, Rheumatology and Clinical Immunology, University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, the Netherlands. E-mail: f.maas@umcg.nl. Accepted for publication October 5, 2015.
Anneke Spoorenberg
From the Department of Rheumatology and Clinical Immunology, Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen; Department of Rheumatology, Medical Center Leeuwarden, Leeuwarden, the Netherlands. The GLAS cohort was supported by an unrestricted grant from Pfizer. F. Maas, MSc, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; S. Arends, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, and Department of Rheumatology, Medical Center Leeuwarden; E. van der Veer, PhD, Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen; F. Wink, MD, Department of Rheumatology, Medical Center Leeuwarden; M. Efde, MD, Department of Rheumatology, Medical Center Leeuwarden; H. Bootsma, MD, PhD, Professor, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; E. Brouwer, MD, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; A. Spoorenberg, MD, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Department of Rheumatology, Medical Center Leeuwarden. Address correspondence to F. Maas, Rheumatology and Clinical Immunology, University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, the Netherlands. E-mail: f.maas@umcg.nl. Accepted for publication October 5, 2015.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Obesity Is Common in Axial Spondyloarthritis and Is Associated with Poor Clinical Outcome
Fiona Maas, Suzanne Arends, Eveline van der Veer, Freke Wink, Monique Efde, Hendrika Bootsma, Elisabeth Brouwer, Anneke Spoorenberg
The Journal of Rheumatology Dec 2015, jrheum.150648; DOI: 10.3899/jrheum.150648
Obesity Is Common in Axial Spondyloarthritis and Is Associated with Poor Clinical Outcome
Fiona Maas, Suzanne Arends, Eveline van der Veer, Freke Wink, Monique Efde, Hendrika Bootsma, Elisabeth Brouwer, Anneke Spoorenberg
The Journal of Rheumatology Dec 2015, jrheum.150648; DOI: 10.3899/jrheum.150648